Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRÊT: Akynzeo Prophylaxis for Emetogenic Radiotherapy
NCT07882966Phase 2Not yet recruiting
- Sponsor
- University Health Network
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in Nausea and Vomiting, sponsored by University Health Network. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
palonosetron
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NCT07882966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882966.